Veracyte Leadership

The Veracyte executive team leads strategy, science, and operations to develop high-performing molecular tests that provide biological insights, helping clinicians and patients make more personalized, informed decisions in thyroid, prostate, breast, bladder, and lung cancer care.

The Veracyte Board of Directors is comprised of experienced leaders in life sciences, genomics, artificial intelligence, and diagnostics. They provide governance and strategic guidance to expand access and adoption of the Veracyte Diagnostics Platform across the United States and worldwide.

The Veracyte Scientific and Technology Advisory Board is comprised of distinguished leaders in medicine, cancer genomics, biotechnology, and diagnostics. They provide scientific and strategic guidance to advance the Veracyte Diagnostics Platform and support the development of innovative diagnostic solutions that improve patient care worldwide. The board includes independent external advisors as well as select members of the Veracyte Board of Directors.